Medication info
Empagliflozin/Metformin Hydrochloride Tablets 12.5/1000 mg

Empagliflozin/Metformin Hydrochloride Tablets 12.5/1000 mg

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›12.5mg / 1 tabletMetformin Hydrochloride›1000mg / 1 tablet
Manufacturer / importer
Dong-Wha Pharmaceutical Co., Ltd.
Appearance
Biconvex oval film-coated tablets with a dark brown tint and purple color.
Packaging
10 tablets/box [10 tablets/PTP × 1], 60 tablets/box [10 tablets/PTP × 6], 30 tablets/bottle, 60 tablets/bottle
Approval status
Active

MFDS item code 202302635 · Approved 2023.09.05 · Insurance code 642707490

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of the individual components: empagliflozin 25 mg and metformin 2000 mg. For patients who are unable to achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). Patients switching from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin to this medicine should receive their current doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia. This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months. If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately. In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.

Ingredients

Manufacturer
Dong-Wha Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Difficulty controlling blood glucose
  • type 2 diabetes
  • cardiovascular diseases
  • cardiovascular events
View approved original text

This medication is used to improve blood glucose control in adult patients with type 2 diabetes, in conjunction with diet and exercise. It is particularly suitable for patients whose blood glucose levels are not adequately controlled and should be used with caution in patients with accompanying cardiovascular diseases. In short, this drug aids in improving blood glucose levels and maintaining cardiovascular health.

How to take

Adult dose

The recommended dose is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of the individual components: empagliflozin 25 mg and metformin 2000 mg. For patients who are unable to achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). Patients switching from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin to this medicine should receive their current doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia. This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months. If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately. In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.

Precautions

This medication is used for the treatment of diabetes and helps control blood glucose levels. However, it can cause a rare side effect called severe lactic acidosis, so it should not be used in patients with poor heart or kidney function. Additionally, there is a risk of hypoglycemia when used with insulin or other diabetes medications, so caution is needed. Patients with moderate to severe kidney function impairment, acute kidney problems, severe infections, heart failure, and other specific conditions should not take this medication. This medication should be temporarily discontinued before and after using iodine contrast agents for examinations, and can be resumed once kidney function has recovered. Pregnant or breastfeeding women should not take this medication, and it is also not recommended for children or adolescents under 18 years of age. Elderly patients should regularly monitor their kidney function, and dosage adjustments may be necessary. Patients taking this medication should carefully observe their hydration status in case of dehydration or gastrointestinal disturbances (nausea, vomiting, etc.), and may need to temporarily stop the medication if needed. This drug may increase the risk of urinary and genital infections, so if any symptoms of infection appear, consult a doctor immediately. Vitamin B12 levels may decrease, so regular checks may be necessary for those taking it long term. Alcohol may increase the risk of side effects of this medication, so avoid excessive drinking during treatment. Also, this medication may interact with other drugs, so inform your doctor or pharmacist if you are taking other medications. If symptoms of hypoglycemia (dizziness, cold sweat, severe fatigue, etc.) occur while taking this medication, check your blood glucose level immediately and take appropriate measures. Before surgery, discontinue this medication at least 48 hours prior, and can resume once kidney function returns to normal thereafter. Regular blood tests and kidney function monitoring are important during the use of this medication to check for any abnormalities.

Side effects

Hypoglycemia, urinary tract infection, genital infection, increased urination, decreased and deficiency of vitamin B12, ketoacidosis, lactic acidosis, reduced fluid volume, nausea, vomiting, diarrhea, abdominal pain, loss of appetite, constipation, abnormal liver function tests, hepatitis, taste disturbance, itching, rash, urticaria, erythema nodosum, dysuria, interstitial nephritis, thirst, increased serum lipids, increased serum creatinine, decreased glomerular filtration rate, increased hematocrit, necrosis of the perineum, vaginal moniliasis, vulvovaginitis, balanitis, fluid volume loss, increased serum creatinine, decreased glomerular filtration rate, gastrointestinal symptoms (diarrhea, nausea, vomiting), chronic gastritis, cerebral infarction, soft tissue infection, pneumonia, ankle fracture, epicondylitis, facial bone fracture, musculoskeletal pain, myocardial infarction, urosepsis, pyelonephritis, rash, urticaria, angioedema, necrosis of the perineum, chronic gastritis, constipation, gastritis, abdominal discomfort, anal incontinence, dry mouth, gastrointestinal disorders, gastroesophageal reflux disease, oral discomfort, salivary gland pain, cerebral infarction, headache, sensory loss, postural dizziness, dizziness, cerebral infarction, headache, postural dizziness, hypercholesterolemia, dyslipidemia, vitamin D deficiency, nasopharyngitis, soft tissue infection, pneumonia, upper respiratory tract infection, asthenia, chest discomfort, chest pain, ankle fracture, epicondylitis, facial bone fracture, ligament injury, ligament sprain, arthralgia, back pain, musculoskeletal pain, bone loss, urinary stones, weight loss, vulvar pruritus, benign prostatic hyperplasia, diabetic retinopathy, diplopia, hypertension, insomnia, dizziness, constipation, nasopharyngitis, shingles, headache, chest discomfort, chest pain, asthenia, weight loss, vulvar pruritus, genital pruritus, dyslipidemia, hyperglycemia, dermoid cyst, seborrheic dermatitis, atopic dermatitis, diabetic foot, nummular eczema, heat rash, sebaceous gland hyperplasia, lumbar spinal stenosis, myalgia, limb pain, musculoskeletal chest pain, arthralgia, cervical stenosis, fibromyalgia, flank pain, fracture pain, muscle weakness, osteoarthritis, osteoporosis, rotator cuff syndrome, astigmatism, cataract, allergic conjunctivitis, blurred vision, corneal erosion, glaucoma, macular fibrosis, ocular discomfort, ocular hyperemia, pathological myopia, retinal detachment, retinal crystals, retinal vein occlusion, macular retinal detachment, eyelid swelling, visual impairment, vitreous floaters, vitreous hemorrhage, epistaxis, asthma, exertional dyspnea, wet cough, allergic rhinitis, residual phlegm, cough, epistaxis, allergic rhinitis, limb injuries, skin laceration, contusion, rib fracture, concussion, corneal abrasion, falls, hand fracture, iliotibial band syndrome, open globe injury, pelvic fracture, road traffic accident, splenic injury, sternum fracture, angina, palpitations, Prinzmetal angina, coronary artery disease, tachycardia, atherosclerosis, deep vein thrombosis, diabetic vascular complications, peripheral arterial occlusive disease, anxiety, depression, sleep disorders, acute cholecystitis, autoimmune hepatitis, cholelithiasis, hepatitis, otalgia, postural vertigo, vertigo, anemia, lymphadenopathy, hypothyroidism, thyroid nodule, unstable angina

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is best to maintain storage temperatures between 1 to 30 degrees Celsius to safely preserve its efficacy.

Appearance and packaging

Appearance

Biconvex oval film-coated tablets with a dark brown tint and purple color.

Package unit

10 tablets/box [10 tablets/PTP × 1], 60 tablets/box [10 tablets/PTP × 6], 30 tablets/bottle, 60 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.